Impact of β-Lactamase Inhibition on the Activity of Ceftaroline against Mycobacterium tuberculosis and Mycobacterium abscessus

被引：36
|
作者：
Dubee, Vincent [1 ,2 ,3 ,4 ]
Soroka, Daria [1 ,2 ,3 ]
Cortes, Melanie [1 ,2 ,3 ]
Lefebvre, Anne-Laure [1 ,2 ,3 ]
Gutmann, Laurent [1 ,2 ,3 ,5 ]
Hugonnet, Jean-Emmanuel [1 ,2 ,3 ]
Arthur, Michel [1 ,2 ,3 ]
Mainardi, Jean-Luc [1 ,2 ,3 ,5 ]
机构：
[1] INSERM, LRMA, Ctr Rech Cordeliers, Equipe 12,UMR S 1138, Paris, France
[2] Univ Paris 06, Sorbonne Univ, Ctr Rech Cordeliers, UMR S 1138, Paris, France
[3] Univ Paris 05, Ctr Rech Cordeliers, Sorbonne Paris Cite, UMR S 1138, Paris, France
[4] Hop St Antoine, AP HP, Serv Reanimat Med, F-75571 Paris, France
[5] Hop Europeen Georges Pompidou, AP HP, Paris, France
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2015年 / 59卷 / 05期
关键词：
MASSILIENSE; CEPHALOSPORIN; INFECTIONS; ACID;
D O I：
10.1128/AAC.05080-14
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The production of beta-lactamases BlaMab and BlaC contributes to beta-lactam resistance in Mycobacterium abscessus and Mycobacterium tuberculosis, respectively. Ceftaroline was efficiently hydrolyzed by these enzymes. Inhibition of M. tuberculosis BlaC by clavulanate decreased the ceftaroline MIC from >= 256 to 16 to 64 mu g/ml, but these values are clinically irrelevant. In contrast, the ceftaroline-avibactam combination should be evaluated against M. abscessus since it inhibited growth at lower and potentially achievable drug concentrations.
引用
收藏
页码：2938 / 2941
页数：4
相关论文
共 50 条
  • [1] Inhibition of the β-Lactamase BlaMab by Avibactam Improves the In Vitro and In Vivo Efficacy of Imipenem against Mycobacterium abscessus
    Lefebvre, Anne-Laure
    Le Moigne, Vincent
    Bernut, Audrey
    Veckerle, Carole
    Compain, Fabrice
    Herrmann, Jean-Louis
    Kremer, Laurent
    Arthur, Michel
    Mainardi, Jean-Luc
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2017, 61 (04)
  • [2] Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
    Bich Hanh, Bui Thi
    Quang, Nguyen Thanh
    Park, Yujin
    Heo, Bo Eun
    Jeon, Seunghyeon
    Park, June-Woo
    Jang, Jichan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [3] Bactericidal and intracellular activity of β-Iactams against Mycobacterium abscessus
    Lefebvre, Anne-Laure
    Dubee, Vincent
    Cortes, Melanie
    Dorchene, Delphine
    Arthur, Michel
    Mainardi, Jean-Luc
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (06) : 1556 - 1563
  • [4] In Vivo Evaluation of Antibiotic Activity Against Mycobacterium abscessus
    Lerat, Isabelle
    Cambau, Emmanuelle
    Bettoni, Romain Roth Dit
    Gaillard, Jean-Louis
    Jarlier, Vincent
    Truffot, Chantal
    Veziris, Nicolas
    JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (06) : 905 - 912
  • [5] In vitro activity of new combinations of β-lactam and β-lactamase inhibitors against the Mycobacterium tuberculosis complex
    Lundeberg, Elin Economou
    Andersson, Viktoria
    Wijkander, Maria
    Groenheit, Ramona
    Mansjo, Mikael
    Werngren, Jim
    Cortes, Teresa
    Barilar, Ivan
    Niemann, Stefan
    Merker, Matthias
    Koser, Claudio U.
    Davies Forsman, Lina
    MICROBIOLOGY SPECTRUM, 2023, 11 (05):
  • [6] In vitro activity of cefoxitin and imipenem against Mycobacterium abscessus complex
    Lavollay, M.
    Dubee, V.
    Heym, B.
    Herrmann, J. -L.
    Gaillard, J. -L.
    Gutmann, L.
    Arthur, M.
    Mainardi, J. -L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (05) : O297 - O300
  • [7] In Vitro Activity of TP-271 against Mycobacterium abscessus, Mycobacterium fortuitum, and Nocardia Species
    Cynamon, Michael
    Jureller, Jeff
    Desai, Balaji
    Ramachandran, Krithika
    Sklaney, Mary
    Grossman, Trudy H.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (07) : 3986 - 3988
  • [8] In Vitro and Intracellular Activity of Imipenem Combined with Rifabutin and Avibactam against Mycobacterium abscessus
    Le Run, Eva
    Arthur, Michel
    Mainardi, Jean-Luc
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (08)
  • [9] Who is the criminal? Isolates of Mycobacterium tuberculosis, Mycobacterium abscessus and Mycobacterium gordonae from a patient with pulmonary disease
    Wei, Jianhao
    Jiang, Yi
    Li, Guilian
    Guo, Qian
    Liu, Haican
    Xu, Donglei
    Zheng, Jianghua
    Wan, Kanglin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 7733 - 7738
  • [10] In Vitro Activity of the New β-Lactamase Inhibitors Relebactam and Vaborbactam in Combination with β-Lactams against Mycobacterium abscessus Complex Clinical Isolates
    Kaushik, Amit
    Ammerman, Nicole C.
    Lee, Jin
    Martins, Olumide
    Kreiswirth, Barry N.
    Lamichhane, Gyanu
    Parrish, Nicole M.
    Nuermberger, Eric L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
12345